Simferopol, Simferopol, Russian Federation
Simferopol, Simferopol, Russian Federation
Simferopol, Simferopol, Russian Federation
Precancerous and inflammatory diseases of the oral mucosa are an urgent problem of modern dentistry, due to the complexity and multifactorial pathogenesis, difficulties in diagnosis and resistance to traditional methods of treatment. Among a number of diseases particular interest is to diseases of the oral mucosa, which are accompanied by specific changes in the epithelium due to chronic inflammation, characterized by impaired keratinization processes, including hyper- and parakeratosis. Among the available arsenal of drugs and non-drug methods of exposure, including physiotherapy, there is currently no drug or combination that would lead to good clinical results in a short time, so the search for an «ideal» drug continues. In this regard, we performed a clinical and cytological assessment of the effectiveness of the use of drugs containing acid solutions with keratolytic and anti-inflammatory effects (Solkovagin and Solkoderm) in the local treatment of verrucous leukoplakia of the oral mucosa. Clinical studies have found that the use of these drugs contributes not only to the fastest (reduction of the duration of treatment time by 3 days) clinical recovery, but also ensures the normalization of cytological parameters. The results obtained allow us to recommend Solkovagin and Solkoderm for widespread use in dental practice as products for local therapy of verrucous leukoplakia of the oral mucosa.
leukoplakia, chronic inflammation, precancerous conditions, treatment, keratolytic therapy
1. 1. Danilevskij N. F., Leont`ev V. K., Nesin A. F., Raxnij Zh. I. Diseases of oral mucosa. Moskva: OAO «Stomatologiya», 2001. (In Russ).
2. Andrianova I. I., Kolesnik V. M., Duryagina L. X. Prospects for conservative therapy of warty form of oral mucosal leukoplakia using «Solkovagin» and «Solkoderma». Ukraїns`kij stomatologіchnij al`manax. 2013;6:10-14. (In Russ).
3. Syomkin V. A., Rabinovich O. F., Babichenko I. I., BezrukovA. A. Leukoplakia: clinical and pathological diagnosis Stomatologiya. 2017;1:72-76 (In Russ). doi:10.17116/stomat201796172-76
4. Goncharic P. V., Suprunovsky R. N., Panasiyk G. D. Leukoplakia of the oral mucous. Gomel: GU «RNPCRMiECH». 2019:27. (In Russ).
5. Arduino P. G. Urban legends series: oral leukoplakia. Oral Diseases.2013;19(7):642–659.
6. Gillenwater A. M, Vigneswaran N, Fatani H, Saintigny P, El-Naggar A. K. Proliferative Verrucous Leukoplakia (PVL): A Review of an Elusive Pathologic Entity. Advances in Anatomic Pathology. 2013;20(6):416-423. doi:10.1097/ pap.0b013e3182a92df1
7. Starzyńska A. Oral premalignant lesions: epidemiological and clinical analysis in the northern Polish population. Postpy Dermatologii i Alergologii. 2014;31(6):341–350.
8. Gandolfo S., Castellani R., Pentenero M. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites. J Periodontol. 2009;80(2):274-281. doi: 10.1902/ jop.2009.080329
9. Pozdnyakova T., Zujkov Yu. Alternative methods of management of oral warty leukoplakia. Cathedra-Kafedra. Stomatologicheskoe obrazovanie. 2007;6(1):24-27. (In Russ).
10. Patent №36750. UA. Method for the treatment of mucosal leukoplakia mouth porosity shell / Zhurochko O.І., Kolesnik V.M., Andrіanova І.І. – Publ. 10.11.2008. (In Ukrain).
